Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug Nereus

Alembic Pharma secures USFDA okay for Doxycycline Capsules for inflammatory lesions of rosacea

Written By Ruchika Sharma28 Jun 2024 5:41 PM IST

Alembic Pharmaceuticals Limited today announced that the Company has received final approval from the US Food & Drug Administration (USFDA) for...

Granules India packaging facility in US successfully completes USFDA inspection

Jubilant Ingrevia receives USFDA EIR for Baruch facility

Written By Ruchika Sharma28 Jun 2024 12:30 PM IST

Noida: Jubilant Ingrevia Limited has announced successful outcome of the USFDA inspection with the receipt of Establishment Inspection report...

Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant

Lupin bags USFDA tentative nod for Olopatadine Hydrochloride Ophthalmic Solution(OTC)

Written By Ruchika Sharma28 Jun 2024 11:30 AM IST

The solution is indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander.

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

USFDA issues complete response letter for Patritumab Deruxtecan in EGFR-Mutated NSCLC: Merck, Daiichi Sankyo

Written By Ruchika Sharma28 Jun 2024 10:00 AM IST

Rahway: The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA)...

Merck KGaA in late-stage talks to acquire SpringWorks for USD 3.5 billion

Merck discontinues Phase 3 trial of Xevinapant in locally advanced head and neck cancer

Written By Ruchika Sharma27 Jun 2024 5:04 PM IST

Germany: Merck, a science and technology company, has announced the discontinuation of the Phase III randomized TrilynX study evaluating...

Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe

Aurobindo Pharma arm Telangana injectable unit gets USFDA VAI classification

Written By Ruchika Sharma27 Jun 2024 3:03 PM IST

Telangana: Aurobindo Pharma has informed in a BSE filing that the injectable facility of Eugia SEZ Pvt. Ltd., a 100 per cent step-down subsidiary...

Dr Reddys, Zydus recall products in US over manufacturing issues

Glenmark Pharma recalls 114 batches of hypokalemia drug Potassium Chloride Extended Release in US

Written By Ruchika Sharma27 Jun 2024 12:20 PM IST

Mahwah: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ is voluntarily recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750...

Bharat Biotech, Biofabri ink technology transfer deal for TB vaccine MTBVAC

Bharat Biotech adds ICMR as co-owner of COVID vaccine patent

Written By Ruchika Sharma26 Jun 2024 4:13 PM IST

Hyderabad: The Indian Council of Medical Research (ICMR) has been added as co-owner of the Covid-19 vaccine patent by Bharat...

Solara Active Pharma Gets EIR for Puducherry Ibuprofen Plant Post USFDA Inspection

USFDA concludes inspection at Shilpa Medicare Hyderabad unit with zero observations

Written By Ruchika Sharma26 Jun 2024 1:30 PM IST

Karnataka: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has concluded the inspection at the Company's Bio...

Ciplas Lanreotide Supply Partners Greece Plant Gets USFDA OAI Status

Cipla Patalganga facility gets VAI classification from USFDA

Written By Ruchika Sharma26 Jun 2024 12:30 PM IST

Mumbai: Through a recent BSE filing, Cipla has informed that the United States Food and Drug Administration (USFDA) has classified the routine...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

USFDA issues EIR for Alkem Labs Baddi facility

Written By Ruchika Sharma25 Jun 2024 4:48 PM IST

Mumbai: Alkem Labs has informed in a BSE filing that the US Food and Drug Administration (US FDA) has issued an Establishment Inspection Report...

Health Ministry Proposes Notification-Based Approval for Pharma Export BE Studies Instead of Central Licensing Authority Nod

American lawmakers question FDAs drug inspection programme in India, China

Written By Ruchika Sharma25 Jun 2024 12:30 PM IST

Washington: Three prominent American lawmakers have questioned the Food and Drug Administration's foreign drug inspection program in India and...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok